# Multi-debate Case Study
- sampleIndex: 6144
- entities: {"drug":"DB02116","protein":"CACNA1C","disease":"MONDO:0005252"}
- groundTruth: 0
- finalDecision: label=0, status=refuted, confidence=0.8
- rationale: Majority vote refutes the triplet: 4 agents voted 0 and 0 agents voted 1.

## Round 1
- roundSummary: Round 1: supports=3, contradictions=6, unresolved_disagreements=3.
- objective: Establish first-pass position
- directive: Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote.
- responseRequirement: State a binary vote and name the strongest positive or negative claim you are relying on.
- board.status: agreement
- board.voteSummary:
  - (none)
- board.positiveEvidence:
  - (none)
- board.negativeEvidence:
  - (none)
- board.contestedClaims:
  - (none)
- currentRound.disagreements:
  - drug contradiction [initial] What evidence contradicts a mechanism or target link between DB02116 and CACNA1C?
  - protein contradiction [initial] What evidence contradicts CACNA1C being disease-relevant for MONDO:0005252?
  - disease contradiction [initial] What evidence contradicts MONDO:0005252 supporting CACNA1C as disease-relevant?

### DRUG agent
- vote: 0
- summary: Drug-side expert votes 0 for the current hypothesis in this round.
- input.roundObjective: Establish first-pass position | Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote.
- input.roleDisagreementsFromPreviousRound:
  - (none)
- input.peerAssessmentSummaries:
  - (none)
- evidenceItems:
  - contradicts/moderate via drug_researcher: Drug profile for DB02116. Name: OLOMOUCINE. Local protein grounding for CACNA1C: Voltage-gated L-type calcium channel. External mechanism text was interpreted against this local alias context first. Local node context was designated as the primary grounding source for this review. Primary local node grounding: Local node context for drug DB02116. Name: Olomoucine. Description: A 9 H -purine that is substituted by a (2-hydroxyethyl)nitrilo, benzylnitrilo and a methyl group at positions 2,6 and 9, respectively. It is a cyclin-dependent kinase inhibitor SMILES: CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1 Targeted review mode: broad. Focused question: Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote. Round focus: Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote. | drug-protein evidence. Active hypotheses for this round: The drug side provides direct mechanism or target evidence for the queried protein. Checks: drug-protein evidence | mechanism or target evidence. Protein grounding aliases: cacna1c, calcium channel, voltage gated calcium channel, l type calcium channel, voltage-gated l-type calcium channel, voltage gated l type calcium channel, this gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. the alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. the calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. there are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. the protein encoded by this gene binds to and is inhibited by dihydropyridine. alternative splicing results in many transcript variants encoding different proteins. some of the predicted proteins may not produce functional ion channel subunits. [provided by refseq, oct 2012], this gene encodes an alpha 1 subunit of a voltage dependent calcium channel. calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. the alpha 1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. the calcium channel consists of a complex of alpha 1, alpha 2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. there are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. the protein encoded by this gene binds to and is inhibited by dihydropyridine. alternative splicing results in many transcript variants encoding different proteins. some of the predicted proteins may not produce functional ion channel subunits. [provided by refseq, oct 2012].
  - supports/weak via node_context: Local node context for drug DB02116. Name: Olomoucine. Description: A 9 H -purine that is substituted by a (2-hydroxyethyl)nitrilo, benzylnitrilo and a methyl group at positions 2,6 and 9, respectively. It is a cyclin-dependent kinase inhibitor SMILES: CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1
  - contradicts/moderate via biomedical_expert_reasoner: Olomoucine is a cyclin-dependent kinase inhibitor with no direct or mechanistic evidence supporting interaction or targeting of the CACNA1C voltage-gated L-type calcium channel protein; no known pharmacological or biochemical data link Olomoucine to modulation of CACNA1C relevant to the disease context.
- toolTrace:
  - drug_researcher
    - interpreted: supports/moderate | Drug researcher found mechanism-relevant language aligned with protein CACNA1C (cacna1c).
    - args: focusMode=broad ; focus=Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote. || drug-protein evidence
    - raw: Drug profile for DB02116. Name: OLOMOUCINE. Local protein grounding for CACNA1C: Voltage-gated L-type calcium channel. External mechanism text was interpreted against this local alias context first. Local node context was designated as the primary grounding source for this review...
  - node_context
    - interpreted: supports/moderate | Drug researcher found mechanism-relevant language aligned with protein CACNA1C (cacna1c).
    - raw: Local node context for drug DB02116. Name: Olomoucine. Description: A 9 H -purine that is substituted by a (2-hydroxyethyl)nitrilo, benzylnitrilo and a methyl group at positions 2,6 and 9, respectively. It is a cyclin-dependent kinase inhibitor SMILES: CN1C=NC2=C1N=C(NCCO)N=C2NCC...
  - biomedical_expert_reasoner
    - interpreted: contradicts/moderate | Olomoucine is a cyclin-dependent kinase inhibitor with no direct or mechanistic evidence supporting interaction or targeting of the CACNA1C voltage-gated L-type calcium channel protein; no known pharmacological or biochemical data link Olomoucine to modulation of CACNA1C relevant to the disease context.
    - args: role=drug
    - raw: [biomedical_expert_reasoner] The drug-side model voted 0 using retrieved evidence plus biomedical reasoning.

### PROTEIN agent
- vote: 0
- summary: Protein-side expert votes 0 for the current hypothesis in this round.
- input.roundObjective: Establish first-pass position | Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote.
- input.roleDisagreementsFromPreviousRound:
  - (none)
- input.peerAssessmentSummaries:
  - (none)
- evidenceItems:
  - contradicts/moderate via protein_researcher: Protein profile for CACNA1C. Protein: Voltage-dependent L-type calcium channel subunit alpha-1C. Organism: Homo sapiens. Function description (from UniProt): Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:12181424, PubMed:15454078, PubMed:15863612, PubMed:16299511, PubMed:17224476, PubMed:20953164, PubMed:23677916, PubMed:24728418, PubMed:26253506, PubMed:27218670, PubMed:29078335, PubMed:29742403, PubMed:30023270, PubMed:30172029, PubMed:34163037, PubMed:8099908). Mediates influx of calcium ions into the cytoplasm, and thereby triggers calcium release from the sarcoplasm (By similarity). Plays an important role in excitation-contraction coupling in the heart. Required for normal heart development and normal regulation of heart rhythm (PubMed:15454078, PubMed:15863612, PubMed:17224476, PubMed:24728418, PubMed:26253506). Required for normal contraction of smooth muscle cells in blood vessels and in the intestine. Essential for normal blood pressure regulation via its role in the contraction of arterial smooth muscle cells (PubMed:28119464). Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group (Probable) Key biological processes (from UniProt GO annotations) include: calcium ion import across plasma membrane, calcium ion transmembrane transport, calcium ion transmembrane transport via high voltage-gated calcium channel, calcium ion transport into cytosol, camera-type eye development. Reported subcellular localization includes: cilium; cytoplasm; dendrite; L-type voltage-gated calcium channel complex. Reactome pathways include: Adrenaline,noradrenaline inhibits insulin secretion, NCAM1 interactions, Regulation of insulin secretion, Phase 0 - rapid depolarisation, Phase 2 - plateau phase. Local node context was designated as the primary grounding source for this review. Primary local node grounding: Local node context for protein CACNA1C. Name: Voltage-gated L-type calcium channel. Description: This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012] Sequence preview: MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTPGAALSWQAAIDAARQAKLMGSAGNATISTVSSTQ... Targeted review mode: broad. Focused question: Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote. Round focus: Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote. | protein-disease evidence. Active hypotheses for this round: The protein side provides disease-specific relevance for the queried disease. Checks: protein-disease evidence | pathway, phenotype, or mechanistic support.
  - supports/weak via node_context: Local node context for protein CACNA1C. Name: Voltage-gated L-type calcium channel. Description: This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012] Sequence preview: MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTPGAALSWQAAIDAARQAKLMGSAGNATISTVSSTQ...
  - contradicts/weak via biomedical_expert_reasoner: CACNA1C encodes a voltage-gated L-type calcium channel alpha-1 subunit important in cardiac and smooth muscle function, but there is no direct or disease-specific evidence linking CACNA1C to the queried disease MONDO:0005252. The protein’s known biological roles do not explicitly overlap with the disease pathology, and no relevant pathways or processes were matched to the disease.
- toolTrace:
  - protein_researcher
    - interpreted: contradicts/weak | Protein researcher returned both biological-process and pathway annotations for MONDO:0005252, but without explicit disease-specific alignment this should remain insufficient.
    - args: focusMode=broad ; focus=Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote. || protein-disease evidence
    - raw: Protein profile for CACNA1C. Protein: Voltage-dependent L-type calcium channel subunit alpha-1C. Organism: Homo sapiens. Function description (from UniProt): Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:121...
  - node_context
    - interpreted: contradicts/weak | Protein researcher returned both biological-process and pathway annotations for MONDO:0005252, but without explicit disease-specific alignment this should remain insufficient.
    - raw: Local node context for protein CACNA1C. Name: Voltage-gated L-type calcium channel. Description: This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 ...
  - biomedical_expert_reasoner
    - interpreted: contradicts/weak | CACNA1C encodes a voltage-gated L-type calcium channel alpha-1 subunit important in cardiac and smooth muscle function, but there is no direct or disease-specific evidence linking CACNA1C to the queried disease MONDO:0005252. The protein’s known biological roles do not explicitly overlap with the disease pathology, and no relevant pathways or processes were matched to the disease.
    - args: role=protein
    - raw: [biomedical_expert_reasoner] The protein-side model voted 0 using retrieved evidence plus biomedical reasoning.

### DISEASE agent
- vote: 0
- summary: Disease-side expert votes 0 for the current hypothesis in this round.
- input.roundObjective: Establish first-pass position | Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote.
- input.roleDisagreementsFromPreviousRound:
  - (none)
- input.peerAssessmentSummaries:
  - (none)
- evidenceItems:
  - supports/weak via node_context: Local node context for disease MONDO:0005252. Name: heart failure. Description: Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction
  - contradicts/weak via biomedical_expert_reasoner: Although CACNA1C encodes a cardiac L-type calcium channel subunit relevant to heart electrophysiology, there is no direct or strong evidence implicating CACNA1C as a therapeutic target or biomarker specifically for heart failure. Heart failure pathophysiology primarily involves contractile dysfunction, remodeling, and neurohormonal activation rather than direct modulation of CACNA1C. Thus, the biological rationale for targeting CACNA1C in heart failure is weak and indirect.
- toolTrace:
  - biomedical_expert_reasoner
    - interpreted: contradicts/weak | Although CACNA1C encodes a cardiac L-type calcium channel subunit relevant to heart electrophysiology, there is no direct or strong evidence implicating CACNA1C as a therapeutic target or biomarker specifically for heart failure. Heart failure pathophysiology primarily involves contractile dysfunction, remodeling, and neurohormonal activation rather than direct modulation of CACNA1C. Thus, the biological rationale for targeting CACNA1C in heart failure is weak and indirect.
    - args: role=disease
    - raw: [biomedical_expert_reasoner] The disease-side model voted 0 using retrieved evidence plus biomedical reasoning.

### GRAPH agent
- vote: 0
- summary: Graph-side expert votes 0 for the current hypothesis in this round.
- input.roundObjective: Establish first-pass position | Build the initial positive and negative case for the queried triplet, then cast a binary 0/1 vote.
- input.roleDisagreementsFromPreviousRound:
  - (none)
- input.peerAssessmentSummaries:
  - (none)
- evidenceItems:
  - contradicts/moderate via graph_reasoner: The graph shows no direct or local closure support for the queried drug-protein-disease triplet (DB02116, CACNA1C, MONDO:0005252), with zero shared drug-protein, drug-disease, or protein-disease edges and no triplet co-occurrence. Although CACNA1C is active in other positive protein-protein and drug-protein-disease neighborhoods, these involve different drugs and diseases, indicating the queried triplet lacks specific graph neighborhood support.
- toolTrace:
  - local_graph_tool
    - interpreted: contradicts/moderate | The graph shows no direct or local closure support for the queried drug-protein-disease triplet (DB02116, CACNA1C, MONDO:0005252), with zero shared drug-protein, drug-disease, or protein-disease edges and no triplet co-occurrence. Although CACNA1C is active in other positive protein-protein and drug-protein-disease neighborhoods, these involve different drugs and diseases, indicating the queried triplet lacks specific graph neighborhood support.
    - raw: Graph retrieval for (DB02116, CACNA1C, MONDO:0005252) excludes the queried hyperedge itself. Same-type positive neighbors: drug-protein=0, drug-disease=0, protein-disease=0. Pair coverage count: 0. Support score: 0. Three-way closure=false. Backbone flags: protein-disease=false, ...
  - graph_reasoner
    - interpreted: contradicts/moderate | The graph shows no direct or local closure support for the queried drug-protein-disease triplet (DB02116, CACNA1C, MONDO:0005252), with zero shared drug-protein, drug-disease, or protein-disease edges and no triplet co-occurrence. Although CACNA1C is active in other positive protein-protein and drug-protein-disease neighborhoods, these involve different drugs and diseases, indicating the queried triplet lacks specific graph neighborhood support.
    - raw: [graph_reasoner] The model voted 0 based on graph evidence and the shared evidence board.

## Arbiter
- summary: Majority-vote arbiter selects 0 from the final agent predictions.
- vote: 0
- evidence:
  - contradicts/strong via majority_vote: Majority vote refutes the triplet: 4 agents voted 0 and 0 agents voted 1.
